Strides Pharma Appoints Biren Gabhawala as Non-Executive Independent Director
Strides Pharma Science Ltd 路 Change in Management 路 30 Oct 2026, 12:33 am
Strides Pharma Appoints Biren Gabhawala as Non-Executive Independent Director Strides Pharma Science Limited's Board approved the appointment of Mr. Biren Gabhawala as a Non-Executive Independent Director for a five-year term starting 1st Nov'26, subject to shareholder approval. The move is part of the company's planned Board succession planning initiative. Gabhawala, a Chartered Accountant and Senior Partner at C.M. Gabhawala & Co. with over 30 years of experience, previously served as Independent Director and Audit Committee Chair at eClerx Services and 3M India, strengthening the company's financial oversight and governance capabilities.
Original exchange filing (PDF)
More announcements from Strides Pharma Science Ltd
- Transcript of Earnings Call pertaining of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 02 Nov 2026
- Audio Recording of Earnings Call pertaining to unaudited Financial Results for the quarter and half year ended September 30, 2026 路 30 Oct 2026
- Allotment of Equity shares pursuant to exercise of Stock Options. 路 30 Oct 2026
- Earnings presentation for the quarter and half year ended September 30, 2026. 路 30 Oct 2026
- Strides Delivers Strong Performance with Q2FY27 Revenue at Rs. 14.297m, Grew 17% YoY. Ex-US Markets Up 31% YoY; EBITDA Up 8% YoY to Rs. 2,509m, Crossing Rs. 2,500m in a Quarter for the First Time. 路 30 Oct 2026
- Financial Results for the quarter and half year ended Sept 30, 2026 路 30 Oct 2026
- Strides Pharma Science Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 30 Oct 2026
- Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 30 Oct 2026
